Company Profile
Foghorn Therapeutics Stock Price, News & Analysis
- Ticker:
- FHTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Foghorn Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
4.14 USD (-0.96%)
Close
Last updated: June 23, 2026 at 00:00
243.08M USD
Market cap
Why the stock is moving
FHTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Foghorn Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Foghorn Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Foghorn Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Foghorn Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Source: Foghorn Therapeutics
- 02
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
Source: Foghorn Therapeutics
- 03
Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update
Source: Foghorn Therapeutics
- 04
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
Source: Foghorn Therapeutics
- 05
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Source: Foghorn Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Foghorn Therapeutics (FHTX)?
Foghorn Therapeutics (FHTX) most recently closed at 4.14 USD, a -0.96% move versus the previous session.
What is the market cap of Foghorn Therapeutics (FHTX)?
Foghorn Therapeutics currently has a market capitalization of 243.08M USD on BioPharmSignal.
What does Foghorn Therapeutics do?
Foghorn Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is FHTX stock listed?
Foghorn Therapeutics (FHTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Foghorn Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Foghorn?
Foghorn Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Foghorn Therapeutics targeting with Foghorn?
Foghorn Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Foghorn Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.